We did a multicentric study under the auspices of the German Austrian Swiss co-operative group DOESAK with 38 tumor centers of OMF-Surgery. Every patient had to fillll the following three criteria: the tumor in the oral cavity had to be a carcinoma; the resection of the tumor had to be performed at least 6 months ago; the surgical treatment had to be intended as radical concerning the tumor and the lymph node dissection. This questionnaire was mailed to 3500 patients, 1761 of them sent back the completed questionnaire. In the course of treatment the rating of pain changed from a preoperatively leading symptom (among 19 factors contributing to the impact of disease index) to a less severe problem (no. 13) post treatment.
Preoperatively pain was mainly caused by the intraoral lesion; in the postoperative period pain was more a result of neck or shoulder-arm problems. 75 % of patients denied any intake of analgetics; NSAID dominated. Physiotherapy seems to be underestimated as an important measure to improve patient's life quality after radical tumor treatment. Severe pain is a common symptom in patients with relapse or metastases in head and neck cancer. Its management may be a challenge for some aspects: (I) oral treatment, the basis of cancer pain treatment according to the WHO ladder, is often impaired by dys-or aphagia, (II) compliance of the patients is sometimes poor (e.g. alcoholism, poor social conditions), (11) many patients with pain suffer from more neuropathic pain following an infiltration or entrapment of cervical or trigeminal nerves. In some cases the feature of atypical pain occured with preauricular or periocular complaints. We treated in the last 10 years 155 patients with severe neck cancer pain. 10% ofthem complained about trigeminal neuralgia or atypical facial pain, 24% about cervical or pancoast neuralgias, 50% about tumour pain by tissue destruction (mainly neck, throat) or bone metastases. 13% of the patients had cancer-associated pain, most of them due to functional disturbances (e.g. muscle pain and tendopathy following neck dissection). The latter group was treated with non-opioids and transcutaneous nerve stimulation. In 89% of patients with cancer pain oral treatment, following the WHO ladder, led to a sufficient pain relief Mostly we used high potent opioids like morphine -etard tablets, buprenorphine or morphine granulate, applied into a gastric tube. In case of neuropathic pain we combined opioids with co-analgetics as antidepressant or anticonvulsant drugs. In few cases transdermal systems using fentanyl were applied recently. Invasive treatments (e.g. nerve or sympathetic blocks, ganglionar opioid injection) was effective in 90% of the remaining 12 patients with opioid-insensitive neuralgia. Longterm epidural (n=2) or parenteral (n=3) opiod treatment was necessary only in single cases, neurodestructive measures could be avoided in the last years.
In conclusion, pain therapy can be managed with (enteral) treatment following the WHO ladder in patients with advanced neck cancer pain also in the case of dysphagia, since new formulations as morphine granulates or 'once the day'-tablets and, as a second step, transdermal systems are available. Invasive measures are still important but only in the subgroup with severe neuralgia or atypical facial pain. Post-neckdissection-pain syndromes, also in patients without a relapse or metastases, lead to a further impairnent of their quality of life. In the most of these patients the accessorius nerve had been ligated. Hence the intraoperative strategy should also consider this problem in the future as far as possible. 
